Rationale and indications for aggressive early thrombus removal

Phlebology

Volumn 27, Issue SUPPL. 1, 2012, Pages 78-84

  Meissner, Mark H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Deep venous thrombosis; Iliofemoral thrombosis; Pharmacomechanical thrombectomy; Thrombectomy; Thrombolysis; Thrombus removal

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTIVITAMIN K; ENOXAPARIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; UROKINASE; WARFARIN;

ACUTE ILIOFEMORAL VENOUS THROMBOSIS; ANTICOAGULANT THERAPY; BLEEDING; CATHETER; CLINICAL TRIAL (TOPIC); COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DISEASE DURATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MECHANICAL THROMBECTOMY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT SAFETY; PATIENT SELECTION; PHLEBOGRAPHY; PHLEGMASIA CERULEA DOLENS; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK REDUCTION; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBECTOMY; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN DISEASE; VEIN THROMBECTOMY; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MECHANICAL THROMBOLYSIS; TIME FACTORS; VENOUS THROMBOSIS; WARFARIN;

EID: 84856803211     PISSN: 02683555     EISSN: 14333031     Source Type: Journal    
DOI: 10.1258/phleb.2012.012S11     Document Type: Review

References (55)

1. Fowkes FJ, Price JF, Fowkes FG. Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg 2003;25:1-5
2. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007;5:692-9
3. Raskob G. Calf-vein thrombosis. In: Hull R, Raskob G, Pineo G, eds. Venous Thromboembolism: An Evidence-Based Atlas. Armonk, NY: Futura Publishing Co., 1996: 307-13
4. Coon WW, Willis PW, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh Community Health Study. Circulation 1973;48:839-46
5. Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 1997;126:454-7
6. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:454S-545S
7. Douketis JD, Crowther MA, Foster GA, Ginsberg JS. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis? Am J Med 2001;110:515-9
8. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular weight heparins with unfractionated heparin in the treatment of venous thromboembolism. Arch Intern Med 2000;160:181-8
9. O'Donnell TF Jr, Browse NL, Burnand KG, Thomas ML. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977;22:483-8
10. Strandness DE, Langlois Y, Cramer M, Randlett A, Thiele BL. Long-term sequelae of acute venous thrombosis. JAMA 1983;250:1289-92
11. Brandjes D, Buller H, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-62
12. Monreal M, Martorell A, Callejas J, et al. Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic syndrome: a prospective trial. J Intern Med 1993;233:233-8
13. Prandoni P, Villalta S, Bagatella P, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997;82:423-8
14. Kahn SR. The post-thrombotic syndrome: progress and pitfalls. Br J Haematol 2006;134:357-65
15. Meissner MH, Gloviczki P, Comerota AJ, et al. Early thrombus removal strategies for acute deep venous thrombosis. Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012 (in press)
16. Warkentin TE, Elavathil LJ, Hayward CP, Johnston MA, Russett JI, Kelton JG. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997;127:804-12
17. Weaver FA, Meacham PW, Adkins RB, Dean RH. Phlegmasia cerulea dolens: therapeutic considerations. South Med J 1988;81:306-12
18. Hood DB, Weaver FA, Modrall JG, Yellin AE. Advances in the treatment of phlegmasia cerulea dolens. Am J Surg 1993;166:206-10
19. Gloviczki P, Hollier LH, Cherry KJ, Pairolero PC, Gale SS, Schirger A. Phlegmasia cerulea dolens: the continuing morbidity. Intl Angiol 1982;1:127-34
20. Qvarfordt P, Eklof B, Ohlin P. Intramuscular pressure in the lower leg in deep vein thrombosis and phlegmasia cerulae dolens. Ann Surg 1983;197:450-3
21. Casey ET, Munrad MH, Zumeta Garcia M, et al. Treatment of acute iliofemoral deep vein thrombosis: a systematic review and meta-analysis. J Vasc Surg 2012 (in press)
22. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the post-thrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008;149:698-707
23. Johnson BF, Manzo RA, Bergelin RO, Strandness DE. Relationship between changes in the deep venous system and the development of the post-thrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one-to six-year follow-up. J Vasc Surg 1995;21:307-13
24. Johnson BF, Manzo RA, Bergelin RO, Strandness DE. The site of residual abnormalities in the leg veins in long-term follow-up after deep venous thrombosis and their relationship to the development of the postthrombotic syndrome. Int Angiol 1996;15:14-9
25. Markel A, Manzo RA, Bergelin RO, Strandness DE. Valvular reflux after deep vein thrombosis: incidence and time of occurrence. J Vasc Surg 1992;15:377-84
26. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993;18:596-608
27. Meissner MH, Caps MT, Bergelin RO, Manzo RA, Strandness DE. Propagation, rethrombosis, and new thrombus formation after acute deep venous thrombosis. J Vasc Surg 1995;22:558-67
28. Prandoni P, Lensing A, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7
29. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993;36:359-64
30. Shull K, Nicolaides A, Fernandes e Fernandes J, et al. Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. Arch Surg 1979;114:1304-6
31. Caps MT, Manzo RA, Bergelin RO, Meissner MH, Strandness DE. Venous valvular reflux in veins not involved at the time of acute deep vein thrombosis. J Vasc Surg 1995;22:524-31
32. Gooley NA, Sumner DS. Relationship of venous reflux to the site of venous valvular incompetence: implications for venous reconstructive surgery. J Vasc Surg 1988;7:50-9
33. van Bemmelen PS, Bedford G, Beach K, Strandness DE Jr. Status of the valves in the superficial and deep venous system in chronic venous disease. Surg 1991;109:730-4
34. Meissner MH, Caps MT, Zierler BK, et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998;28:826-33
35. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis of lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999;211:39-49
36. Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004;239:118-26
37. van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the post-thrombotic syndrome. J Thromb Haemost 2005;3:939-42
38. Gonzalez-Fajardo JA, Arreba E, Castrodeza J, et al. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis. J Vasc Surg 1999;30:283-92
39. Gonzalez-Fajardo JA, Martin-Pedrosa M, Castrodeza J, Tamames S, Vaquero-Puerta C. Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: comparative study of enoxaparin versus coumarin. J Vasc Surg 2008;48:953-9
40. Kakkos SK, Daskalopoulou SS, Daskalopoulos ME, Nicolaides AN, Geroulakos G. Review on the value of graduated elastic compression stockings after deep vein thrombosis. J Thromb Haemost 2006;96:441-5
41. AbuRahma A, Perkins SE, Wulu JT, Ng HK. Ileofemoral deep vein thrombosis: conventional therapy versus lysis and percutaneous transluminal angioplasty and stenting. Ann Surg 2001;233:752-60
42. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984;76:393-7
43. Forster A, Wells P. Tissue plasminogen activator for the treatment of deep venous thrombosis of the lower extremity. Chest 2001;119:572-9
44. Lensing AWA, Hirsh J. Rationale and results of thrombolytic therapy for deep vein thrombosis. In: Bernstein EF, ed. Vascular Diagnosis. 4th edn. St Louis: Mosby, 1993
45. Semba CP, Dake MD. Catheter directed thrombolysis for ileofemoral venous thrombosis. Radiology 1994;191:417-22
46. Elsharawy M, Elzayat E. Early results of thrombolysis vs. anticoagulation in iliofemoral venous thrombosis. A randomized clinical trial. Eur J Vasc Endovasc Surg 2002;24:209-14
47. Comerota AJ, Throm RC, Mathias SD, Haughton SH, Mewissen MW. Catheter-directed thrombolysis for iliofemoral deep vein thrombosis improves health-related quality of life. J Vasc Surg 2000;32:130-7
48. Lin PH, Zhou W, Dardik A, et al. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg 2006;192:782-8
49. Kim HS, Patra A, Paxton BE, Khan J, Streiff MB. Adjunctive percutaneous mechanical thrombectomy for lowerextremity deep vein thrombosis: clinical and economic outcomes. J Vasc Interv Radiol 2006;17:1099-104
50. Comerota AJ. The ATTRACT Trial: Rationale for Early Intervention for Iliofemoral DVT. Persp Vasc Surg Endovasc Ther 2009;21:221-4
51. Enden T, Sandvik L, Klow NE, et al. Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis-the CaVenTstudy: rationale and design of a multicenter, randomized, controlled clinical trial (NCT00251771). Am Heart J 2007;154:808-14
52. Vedantham S, Thorpe PE, Cardella JF, et al. Quality improvement guidelines for the treatment of lower extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2006;17:435-47
53. Guyatt G, Gutterman D, Baumann MH, et al. Grading strength of recommendations and quality of evidence in clinical practice guidelines: report from an American College of Chest Physicians task force. Chest 2006;129:174-81
54. Patel NH, Plorde JJ, Meissner M. Catheter-directed thrombolysis in the treatment of phlegmasia cerulea dolens. Ann Vasc Surg 1998;12:471-5
55. Centeno RF, Nguyen AH, Ketterer C, Stiller G, Chait A, Fallahnejad M. An alternative approach: antegrade catheter-directed thrombolysis in a case of phlegmasia cerulea dolens. Am Surg 1999;65:229-31